Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
100%
Clinical Significance
100%
Lymphoma Cell
75%
Prognostic Factor
50%
Immunohistochemistry
25%
Epileptic Absence
25%
Survival Rate
25%
C Reactive Protein
25%
Enzyme Linked Immunosorbent Assay
25%
Progression Free Survival
25%
B Symptoms
25%
Patient with Non-Hodgkins Lymphoma
25%
Soluble Interleukin 2 Receptor
25%
Nucleoside Diphosphate Kinase A
25%
Immunology and Microbiology
B Cell
100%
Blood Level
100%
Lymphoma Cell
100%
Survival Rate
33%
C-Reactive Protein
33%
ELISA
33%
Progression Free Survival
33%
Interleukin 2 Receptor
33%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
Blood Level
100%
Eicosanoid Receptor
33%
C-Reactive Protein
33%
Survival Rate
33%
Progression Free Survival
33%
Interleukin 2
33%
Pharmacology, Toxicology and Pharmaceutical Science
Diffuse Large B Cell Lymphoma
100%
Symptom
25%
Enzyme-Linked Immunosorbent Assay
25%
Epileptic Absence
25%
Survival Rate
25%
C Reactive Protein
25%
Progression Free Survival
25%
Nonhodgkin Lymphoma
25%
Nucleoside Diphosphate Kinase A
25%
Soluble Interleukin 2 Receptor
25%
Nursing and Health Professions
Patient with Non-Hodgkins Lymphoma
25%
Nucleoside Diphosphate Kinase A
25%
Soluble Interleukin 2 Receptor
25%